One of the most mutated oncogenes in CRC is Kirsten rat sarcoma (KRAS), with more than 40% of patients harboring activating KRAS missense mutations, most frequently in codons 12, 13, and 61 [4]. This evidence concerns the gene KRAS and colorectal carcinoma.